Furthermore, molecular‐level analyses indicate that PKHD1 mutations function as an independent prognostic biomarker for overall survival in colon cancer, distinct from well‐established factors such as TMB and MSI.2, 15. The gene discussed is PKHD1; the disease is colonic neoplasm.